| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.007 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.007 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.007 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.009 |